Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
Guosheng YuanXiao ChengQi LiMengya ZangWei HuangWenzhe FanTao WuJian RuanWencong DaiWenxuan YuMian ChenYabing GuoXiaoyun HuJinzhang ChenPublished in: OncoTargets and therapy (2020)
Camrelizumab and apatinib yielded a promising outcome in patients with advanced HCC who developed a tumor thrombus in the first lower-order portal vein branches and was generally safe and had manageable side effects.
Keyphrases